<div id="readability-page-1"><div><p>Rising inflation worries, higher bond yields and choppy energy markets are putting pressure on weaker companies, especially those that rely heavily on cheap financing to survive. That environment can be harsh for most penny stocks, which often run out of cash before their plans get off the ground. The Elite Penny Stocks screener focuses only on companies with balance sheets that look better equipped to fund their ambitions. In this article, you will see 3 of the most interesting stocks from that list, so you can quickly identify potential high-upside candidates without sifting through hundreds of fragile micro caps.</p> <h2>Grab Holdings (GRAB)</h2> <p><strong>Overview:</strong> Grab Holdings runs a superapp across eight Southeast Asian countries that brings together ride-hailing, food and grocery delivery, digital payments, financial services, advertising and other everyday services for consumers, merchants and drivers on one platform.</p> <p><strong>Operations:</strong> Grab generates most of its revenue from Deliveries at US$1.9b and Mobility at US$1.3b, with smaller contributions from Financial Services at US$379m and Others at US$4m.</p> <p><strong>Market Cap:</strong> US$14.8b</p> <p>Grab stands out in the Elite Penny Stocks screener because it couples a multi-service superapp model with improving profitability and exposure to rising digital adoption in Southeast Asia, while still being valued below some fair value estimates and analyst targets. Q1 2026 results showed higher revenue of US$955m, net income of US$136m and a 10.7% net margin, supported by growing on-demand volume and an expanding financial services arm that is targeting adjusted EBITDA breakeven in H2 2026. At the same time, investors need to weigh risks such as funding entirely through external borrowing, low and forecast-to-remain-low returns on equity, and questions around earnings quality and governance that could matter more if growth or margins slow.</p> <p>Grab’s superapp story is gaining traction, but the real tension sits between rising profitability and questions around earnings quality. Before you decide it is fully priced in, review the 4 key rewards and 1 important major warning sign</p> <figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/42550d29-9c5a-406d-98f7-4e9293ce901e/chart/earnings-and-revenue-growth/query-ZGF0ZT0yMDI2LTA1LTE0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/42550d29-9c5a-406d-98f7-4e9293ce901e/chart/earnings-and-revenue-growth/query-ZGF0ZT0yMDI2LTA1LTE0"/><figcaption>NasdaqGS:GRAB Earnings &amp; Revenue Growth as at May 2026</figcaption></figure> <h2>Marqeta (MQ)</h2> <p><strong>Overview:</strong> Marqeta runs a cloud-based platform that lets businesses issue and manage card programs, handling everything from virtual and physical cards to transaction processing, fraud controls and money movement so customers like fintechs, lenders and on-demand apps can plug payments straight into their products.</p> <p><strong>Operations:</strong> Marqeta generates US$651.6m in revenue from data processing services, with around US$551.2m coming from the United States and US$100.4m from markets outside the United States.</p> <p><strong>Market Cap:</strong> US$1.6b</p> <p>Marqeta gives you exposure to the shift toward card-based embedded finance, with its open API platform supporting use cases from BNPL to gig worker payouts and showing 33% TPV growth alongside GAAP profitability in Q1 2026. The TransactPay acquisition, new CTO hire and growing demand for multinational issuing point to a business trying to deepen its moat, yet the story is not straightforward, with heavy reliance on a few big customers, repeated one off items, rich pricing versus some peers and funding entirely through external borrowing. If you want to understand whether the earnings growth forecasts and recent margin pressure still add up to an attractive risk reward setup here, there is more to examine beneath the headlines.</p> <p>Marqeta’s GAAP profitability and 33% TPV growth could be masking a deeper shift in how this platform earns its money, and the 1 key reward and 2 important warning signs might reveal the one factor that really decides what happens next</p> <figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/992c8690-3ba6-4d48-a98a-f1ceb1d35f42/chart/earnings-and-revenue-growth/query-ZGF0ZT0yMDI2LTA1LTE0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/992c8690-3ba6-4d48-a98a-f1ceb1d35f42/chart/earnings-and-revenue-growth/query-ZGF0ZT0yMDI2LTA1LTE0"/><figcaption>NasdaqGS:MQ Earnings &amp; Revenue Growth as at May 2026</figcaption></figure> <h2>Clover Health Investments (CLOV)</h2> <p><strong>Overview:</strong> Clover Health Investments offers Medicare Advantage plans in the United States and provides preferred provider organization and health maintenance organization coverage for eligible seniors, supported by Clover Assistant, a software platform that helps physicians detect and manage chronic conditions.</p> <p><strong>Operations:</strong> Clover Health generates about US$2.2b in revenue from its Insurance segment, all from the United States.</p> <p><strong>Market Cap:</strong> US$1.9b</p> <p>Clover Health may appeal to investors seeking exposure to Medicare Advantage growth combined with a technology-focused care model, as its Clover Assistant platform supports value-based care and has coincided with the company reporting GAAP net income profitability in Q1 2026 while participating in national interoperability initiatives. The stock screens as heavily discounted relative to some fair value models and trades on a lower P/S than many peers. However, investors still need to consider ongoing GAAP net losses for 2025, reliance on external borrowing and higher medical and pharmacy utilization that can pressure benefit expense ratios. For those weighing these positives and risks, the overall picture is more complex than the headline valuation gap suggests.</p> <p>Clover’s mix of Medicare Advantage scale, a tech driven care model and a heavily discounted share price points to a story investors may be underestimating, and the 3 key rewards and 1 important warning sign could highlight the twist that really matters next</p> <figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b181a9f8-182e-48cc-b994-e8c063d4c75b/chart/past-earnings-growth/query-ZGF0ZT0yMDI2LTA1LTE0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b181a9f8-182e-48cc-b994-e8c063d4c75b/chart/past-earnings-growth/query-ZGF0ZT0yMDI2LTA1LTE0"/><figcaption>NasdaqGS:CLOV Past Earnings Growth as at May 2026</figcaption></figure> <p>The three stocks covered here are just a starting point; the full Elite Penny Stocks screener surfaces 24 more companies with balance sheets and stories that could be just as compelling. Use Simply Wall St to identify and analyze the exact catalysts, funding strength and growth narratives that matter to you so you can focus on the highest conviction opportunities in this corner of the market.</p> <h2>Take Control of Your Investment Journey</h2> <p> If Clover Health Investments or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen.             Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates.             Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives.             By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.         </p> <h2>Seeking Alternatives Before The Crowd Moves?</h2> <p>Fresh stock ideas do not stay under the radar for long. Catch potential breakouts while the data is still flying in your favor. Before the crowd arrives, consider acting sooner rather than later.</p> <ul> <li>Spot companies quietly building momentum in cash flows and balance sheets, then run them through the 45 high quality undervalued stocks while the valuations still look reasonable and under the radar for now.</li> <li>Track firms powering the grid upgrades behind AI and electrification trends by scanning the 38 power grid technology and infrastructure stocks before the story gets fully priced in by latecomers.</li> <li>Zero in on automation leaders where earnings could benefit from long adoption cycles by filtering ideas through the 32 robotics and automation stocks while expectations remain contained and entry points still look sensible.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data         and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your         financial situation. We aim to bring you long-term focused analysis driven by fundamental data.         Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.         Simply Wall St has no position in any stocks mentioned.</em></p><div><h3><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>• Connect an unlimited number of Portfolios and see your total in one currency<br/>• Be alerted to new Warning Signs or Risks via email or mobile<br/>• Track the Fair Value of your stocks<br/></p><p>Try a Demo Portfolio for Free</p></div></div></div>

GRAB

CLOV

<p>The article discusses three elite penny stocks that are well-positioned to withstand rising interest rates and inflation. Grab Holdings operates a multi-service superapp in Southeast Asia, showing improving profitability but facing risks related to external funding and earnings quality. Marqeta provides a cloud-based platform for card management, experiencing significant growth but reliant on a few major clients. Clover Health Investments offers Medicare Advantage plans, leveraging technology for chronic condition management, yet faces ongoing losses and reliance on external borrowing. Investors should weigh the potential rewards against the associated risks for each stock.</p>

3 Elite Penny Stocks With Strength To Withstand Higher Rates